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Diagnostic Accuracy of CMR in
Biopsy-Proven Acute Myocarditis*
Jeanette Schulz-Menger, MDBerlin, GermanyAntagonisms are the driving forces and
the fundament of all existence.
dHegel (1)
Heart failure is a leading problem in clinical car-
diology. The causes are diverse, and treatment must
be tailored according to underlying mechanisms.
Inﬂammatory causes are a particular challenge. With
their study, reported in this issue of iJACC, Fran-
cone et al. (2) intend to narrow the gap in our cur-
rent knowledge regarding the diagnostic workup of
inﬂammatory heart disease, particularly as related
to viral cardiac infections. Whereas endomyocardialSee page 254
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viral pathogens speciﬁcally, the current guidelines
suggest the need for EMB in only in few settings
(3). EMB is not dangerous in experienced hands (4),
and the decision for or against EMB is predicated
on speciﬁc therapeutic relevance and the chances
for recovery (5). A noninvasive workup is preferable
to guide decisions regarding EMB. Cardiovascular
magnetic resonance (CMR) has gained utility in
the diagnostic armamentarium (5). This is because
CMR is able to distinguish between ischemic and
nonischemic processes and to separate acute from
chronic disease, and it predicts reversibility. Inter-
estingly, myocardial injuries are already detectable in
preserved left ventricular function applying CMR.f
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oFrancone et al. (2) studied patients with biopsy-
proven acute myocarditis and assessed the sensitivity
of CMR in this setting. They evaluated 57 conse-
cutive patients who had clinical histories of disease
<3 months in duration. They combined a CMR
protocol aimed at detecting edema, hyperemia,
and/or ﬁbrosis or necrosis. The diagnosis of myocar-
ditis on the basis of CMR ﬁndings was established
when $2 CMR criteria were present. Clinically,
Francone et al. (2) deﬁned 3 distinct myocarditis
groups: infarctlike, cardiomyopathic, and arrhythmic.
The incidence of CMR ﬁndings was different within
the groups. The investigators conclude that in acute
myocarditis, CMR’s sensitivity is high for the infarct-
like pattern, low for the cardiomyopathic pattern, and
very low for the arrhythmic constellation. These re-
sults led the investigators to conclude that EMB may
be required in CMR-negative subjects with electrical
instability (arrhythmias) and/or cardiac deterioration
(worsening heart failure) for a ﬁnal diagnosis.
A notable strength in the presentation is the direct
comparison between CMR and EMB. Nevertheless,
as the investigators themselves point out, the applied
CMR sequences they used are different from the
sequences that are currently recommended. As a
matter of fact, every researcher has the right and the
duty to develop his or her own tools and parameters.
In this case, though, the investigators used published
semiquantitative measures and cutoffs, but they did
not use the dedicated underlying technique (6,7).
That means that their CMR diagnosis of inﬂam-
mation to semiquantify edema and hyperemia was
based on cutoff values that may not reﬂect the
characteristics of the applied sequence. Thus, the use
of the published cutoff values in their study is difﬁ-
cult. As a result, the deﬁnition of CMR diagnosis of
myocarditis, if 2 or more of the investigators’ criteria
are positive, could vary for technical reasons. This is
not a failure of CMR. Other biomarkers, such as
troponin, have internationally accepted cutoff values,
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265although these are subject to variation depending on
the kit manufacturer (8).
There is no absolute “right or wrong,” as Georg
Hegel implied (1). Nonetheless, this publication
strengthens the call for standardization. Often, when a
new method enters the arena, several approaches are
applied, and apparently conﬂicting results are published.
This state of affairs was also the case with CMR-driven
assessment of inﬂammation. The apparent contradic-
tions were based on different scan protocols and/or the
assessment of variable study populations.Thedeﬁnition
of the acuity is also unclear and varies among studies.
The present trial deﬁned acuity as disease duration of
<3 months. Other investigators have deﬁned acuity as
<4 weeks. The underlying pathology, as well as its
impact, may be different within these time frames.
Furthermore, the timing of the scan also inﬂuences
the accuracy of CMR.
The incidence of edema, hyperemia, and necrosis
or ﬁbrosis, as late gadolinium enhancement (LGE)
images indicate, is inﬂuenced by age and sex (9).
This observation means that the relationship be-
tween the clinical patterns, as deﬁned by Francone
et al. (2), and as based on CMR ﬁndings, may be
also inﬂuenced by these variables. It was demon-
strated recently that a positive LGE image indicates
that the patient’s prognosis is worse (10). However,
it is well known that LGE does not occur in all
patients (6). The other CMR parameters are even
more difﬁcult to assess and are based on the semi-
quantitative analysis previously discussed. Whereas
edema imaging is in the meantime accepted,evaluation of hyperemia using the early gadolinium
enhancement method is still under debate, mainly
for technical reasons. However, it has been shown
that early gadolinium enhancement as well as T2
leads to a higher positive likelihood ratio (sensitivity/
[1 – speciﬁcity]) (11). Interestingly, early gadolinium
enhancement and LGE had the best correlation
for the development of heart failure (12). Thus, it
makes sense to invest human and computing re-
sources to improve these techniques, which may
offer insights into different pathophysiologies.
It is assumed that newer quantitative techni-
ques should overcome some limitations. Parametric
mapping is an emerging technique with potential
usefulness in myocarditis. Fortunately, several
volunteer and/or standardization trials are already
published, and ﬁrst experiences in myocarditis are
promising (13–16). Quantitative T2 mapping also
warrants consideration as a robust technique to
identify myocardial injury in patients with acute
myocarditis (17). Diagnostic tools could be im-
proved signiﬁcantly if they could be standardized in
advance rather than retrospectively. First steps are
already in progress regarding scan protocols (18),
post-processing (19), and T1 mapping (20). There
is no doubt that noninvasive diagnostic tools must
be improved. The investigators’ contribution is a
useful step in this direction.
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